Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04151667 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT04151667 · ClinicalTrials.gov record · last posted 2026-08-20

Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

Name: Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma — clinical trial record (NCT04151667)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhasePhase 2

SponsorH. Lee Moffitt Cancer Center and Research Institute

Started2019-11-22

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a Phase II study of daratumumab based therapies for older adults with multiple myeloma.

Protocol amendment history 2 changes detected by DataLookout

2026-08-21

Trial completed

2026-08-21

Completion moved earlier: 2026-05-07 → 2026-03-16

Trial Details

NCT Number	NCT04151667
Lead Sponsor	H. Lee Moffitt Cancer Center and Research Institute Collaborators: Janssen Scientific Affairs, LLC
Conditions	Multiple Myeloma
Enrollment	33 participants
Start Date	2019-11-22
Primary Completion	2023-11-08 (estimated)
Study Completion	2026-03-16 (estimated)
Updated on ClinicalTrials.gov	2026-08-20